Related Experiment Videos

Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS

D C Anthony1, K M Miller, S Fearn

  • 1The CNS Inflammation Group, Department of Pharmacology, University of Oxford, UK. daniel.anthony@pharm.ox.ac.uk

Insights

Specific matrix metalloproteinases (MMPs) and TNF-alpha increase in experimental multiple sclerosis lesions. These MMPs contribute to blood-brain barrier breakdown and myelin damage, suggesting therapeutic targets.

Area of Science:

  • Neuroimmunology
  • Molecular Biology
  • Pathogenesis of Multiple Sclerosis

Background:

  • Matrix metalloproteinases (MMPs) and TNF-alpha are implicated in central nervous system (CNS) inflammation.
  • Their specific roles in the pathogenesis of multiple sclerosis (MS) require further elucidation.

Purpose of the Study:

  • To investigate the expression of various MMPs and TNF-alpha in an experimental DTH model of MS.
  • To determine the contribution of specific MMPs to CNS damage.

Main Methods:

  • Examined mRNA and protein expression of MMPs and TNF-alpha in control and DTH rat brains using RT-PCR and immunohistochemistry.
  • Stereotaxically injected purified MMP-7, MMP-8, and MMP-9 into rat brains to assess their effects.

Main Results:

  • Significant upregulation of MMP-7, MMP-8, MMP-12, and TNF-alpha mRNA and protein was observed in DTH lesions compared to controls.
  • Injected MMP-7, MMP-8, and MMP-9 induced leukocyte recruitment and blood-brain barrier (BBB) breakdown.
  • MMP-7 and MMP-9 injections led to myelin loss.

Conclusions:

  • Specific MMPs are upregulated in experimental MS lesions and correlate with increased protein levels.
  • Upregulated MMPs can directly contribute to BBB disruption, leukocyte infiltration, and myelin damage in the CNS.

Related Concept Videos